Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal MelanomasMatthew G Field, Jeffim N Kuznetsov, Parker L Bussies, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
PRAME as an Independent Biomarker for Metastasis in Uveal MelanomaMatthew G Field, Christina L Decatur, Stefan Kurtenbach, et al.Oncotarget|August 4, 2016
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomasMatthew G Field, Michael A Durante, Christina L Decatur, et al.Science Advances|August 19, 2022
RB1 loss triggers dependence on ESRRG in retinoblastomaMatthew G Field, Jeffim N Kuznetsoff, Michelle G Zhang, et al.Nature Communications|January 26, 2020
Single-cell analysis reveals new evolutionary complexity in uveal melanomaMichael A Durante, Daniel A Rodriguez, Stefan Kurtenbach, et al.Cancers|August 12, 2022
BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal MelanomasChristopher J Kaler, James J Dollar, Anthony M Cruz, et al.Ocular Oncology and Pathology|January 27, 2022
Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal MelanomaKatherina M Alsina, Lauren M Sholl, Kyle R Covington, et al.Clinical Ophthalmology (Auckland, N.Z.)|June 11, 2010
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitisLudimila L Cavalcante, Milena L Cavalcante, Timothy G Murray, et al.Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Early Genetic Evolution of Driver Mutations in Uveal MelanomaJames J Dollar, Christina L Decatur, Ezekiel Weis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2024
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)J William Harbour, Zelia M Correa, Amy C Schefler, et al.Pageof 3